Assessment of Acromegaly Patients With and Without Diabetes Treated With Lanreotide Depot/Autogel (LAN): 2-Year Registry Study Data
AACE ePoster Library. GORDON M. 05/27/16; 131507; 946
Disclosure(s): MBG: Clinical research funding: Ipsen, Novartis, Pfizer, Novo Nordisk, Teva, Opko, Corcept
MM: Advisory board/consultant: Ipsen, Novartis, Chiasma, Corcept; clinical research funding: Ipsen, Novartis
WWW: Advisory board: Chiasma; clinical research funding: Ipsen, Versartis, Novo Nordisk
DWC: Consultant: Ipsen Biopharmaceuticals
OVG, BM, DC: Employees: Ipsen Biopharmaceuticals
RS: Advisory board/consultant: Novartis, Novo Nordisk; clinical research funding: Ipsen, Pfizer, Novartis
MURRAY GORDON
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}